SURREY, UNITED KINGDOM--(Marketwired - October 27, 2016) - Angle PLC (AIM: AGL) (OTCQX: ANPCY)
OTCQX: ANPCY
For immediate release 27 October 2016
ANGLE plc
("ANGLE" or the "Company")
Director's share purchase
ANGLE plc (AIM: AGL OTCQX: ANPCY), the specialist medtech company, announces that it was notified today that Andrew Newland, Chief Executive of ANGLE, has purchased 1,350,000 ordinary shares of 10p each in the Company ("Ordinary Shares"). These shares were purchased at a price of 57 pence per share in accordance with the sale and repurchase agreement (the "Agreement"), as described in the Company's announcement of 12 November 2014.
The Agreement has now terminated and Mr Newland's legal and beneficial interest in the Company reverts to the same level as it was prior to the Agreement, being 7,054,686 Ordinary Shares, now representing 9.43 per cent of the Company's issued share capital.
For further information:
ANGLE plc 01483 685830 Andrew Newland, Chief Executive Ian Griffiths, Finance Director Cenkos Securities 020 7397 8900 Stephen Keys (Nominated adviser) Russell Kerr, Oliver Baxendale (Sales) FTI Consulting 020 3727 1000 Simon Conway, Mo Noonan, Stephanie Cuthbert 001 212 850 5612 Kimberley Ha (US)
This announcement contains inside information.
This information is provided by RNS
The company news service from the London Stock Exchange
END
